DIA 2013 49th Annual Meeting
Click here to go to the previous page
Protocol Deviations: Avoidable Problems or an Unavoidable Risk
Track : Track 11: Innovative Approaches to Ensuring Compliance with Good Clinical Practice (GCP) and Quality Assurance (QA)
Program Code: 427
Date: Thursday, June 27, 2013
Time: 10:45 AM to 12:15 PM  EST
Location: 156C
CHAIR :
 Leslie M. Sam, (SCHNON), Director, Global Quality Systems, Eli Lilly and Company, United States
SPEAKER (S):
 Maryrose Petrizzo, MS (SPKNON), Manager, Clinical Services- Vendor Management, Allergan Inc., United States
 Yvonne P. McCracken, MPH (SPKNON), PMG Research, Inc, United States
Description
There is no consistent terminology or methods to categorize and report protocol deviations. The Good Clinical Practice Quality Assurance (GCP-QA) Community collaborated with industry experts and is working on a paper that will be submitted to a peer reviewed journal for publication. This interactive workshop will share findings and seek your input.

**Due to workshop format, seating will be limited and will be available on a first come, first served basis.

The Boston Convention and Exhibition Center (BCEC) has stringent regulations on maximum room capacities, and they are strictly enforced. Once all seats are occupied, DIA will be required to close the workshop, and no more participants will be admitted. Interested attendees are encouraged to arrive at workshops early in order to ensure seating. Please note, as a workshop with interactivity, this event will not be recorded.